Yuji Kanisawa
Yuji Kanisawa publishes mostly in Hematology, Immunology and Surgery, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Immune Cell Function and Interaction.
- World rank
- #7,517,551 of 7,710,434 ranked researchers
- Rank in Japan
- #360,037 of 383,136
- Works
- 66
- Citations
- 328
- Citations per work
- 5.0
What does Yuji Kanisawa research?
Yuji Kanisawa's work is mostly in Medicine (44%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3146.5%
- Health Sciences2944.5%
- Medicine2944.5%
- Life Sciences69.0%
- 1Hematology18% of their works
- 2Immunology9% of their works
- 3Surgery7% of their works
- 4Genetics7% of their works
- 5Oncology7% of their works
- 6Epidemiology5% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Immune Cell Function and Interaction
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Gastrointestinal Tumor Research and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
Which keywords describe Yuji Kanisawa's research?
The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Chronic Lymphocytic Leukemia, Genomic Aberrations, Imatinib, Acute Myeloid Leukemia, AML and Natural Killer Cells.
- Myelofibrosis
- International Myeloma Working Group
- Diagnosis Criteria
- Platelets
- NK Cell Recognition
- AML
- Genomic Aberrations
- BCR-ABL
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- Imatinib
- Acute Myeloid Leukemia
- Natural Killer Cells
- Thrombosis
- Imatinib Mesylate
- JAK2 Mutation
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Prognostic Factors173 topics
- BCR-ABL71 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Imatinib71 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- NK Cell Recognition61 topic
- Natural Killer Cells61 topic
- Platelets61 topic
- Thrombosis61 topic
- Diagnosis Criteria41 topic
- Imatinib Mesylate41 topic
- International Myeloma Working Group41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Sunitinib41 topic
Where does Yuji Kanisawa work?
Yuji Kanisawa's main affiliation in the publication record is Oji General Hospital, Japan.
How many publications and citations does Yuji Kanisawa have?
OpenAlex counts 66 works and 328 citations for Yuji Kanisawa, an h-index of 9, ranking #7,517,551 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yuji Kanisawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.